Recent Updates
Recently added Catalysts
MRKR

July 22 nd 2019 Peter Hoang President & Chief Executive Officer 1 2 3 Brandon G. Smaglo M.D., FACP Lead investigator and Assistant Professor of Oncology at Baylor College of Medicine 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1

Key Takeaway: Peter Hoang President & Chief Executive Officer Brandon G. Smaglo M.D., FACP Lead investigator and Assistant Professor of Oncology at Baylor College of Medicine

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.1%
average across 5 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
Low dose FRα vaccine
Phase 2 · Breast Cancer

Full Press Release Details

Peter Hoang President & Chief Executive Officer
Brandon G. Smaglo M.D., FACP Lead investigator and Assistant Professor of Oncology at Baylor College of Medicine
Last updated: Jul 22, 2019